The QualityStocks Daily Tuesday, December 18th, 2018

Today's Top 3 StockMarketWatch

NetworkNewsWire (GTXO) +126.13%

QualityStocks (PCSA) +75.61%

BUYINS.NET (BIOC) +66.28%

The QualityStocks Daily Stock List

mCig, Inc. (MCIG)

Shiznit Stocks, Stockgoodies, CFN Media Group, The Street, GrowthPennyStocks, Penny Stock General, MadMoneyPicks, MassiveStockProfits, Wall Street Equities Research, Promotion Stock Secrets, TopPennyStockMovers, Stock Shock and Awe, PennyPro, Fast Money Alerts, Cannabis Financial Network News, and SmallCapVoice reported previously on mCig, Inc. (MCIG), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

mCig, Inc. is a diversified business serving the legal cannabis, hemp, and CBD markets by way of its lifestyle brands. The Company is a distributor of innovative cannabis related products. mCig has transitioned from a vaporizer manufacturer to an industry leading, large scale, full-service cannabis cultivation construction enterprise. Its Scalable Solutions division presently operates in the fast-expanding Nevada market. The Company’s devotion is to be the foremost distributor of technology, products, and services to the industry.  mCig has its corporate office in Henderson, Nevada.

mCig owns the Rollie and Vapolution brands. The Company has its Grow Contractors division that provides services to growers of every level in the developing cannabis industry. This division provides turnkey, durable, completely modular, ISO clean, high-yielding cultivation rooms. This permits growers to create a first-rate growing environment all year.

Regarding Commercial Scale, Grow Contractors utilizes Structurally Insulated Panels to create a hermetically sealed, mold/pest free, and sterile environment. Its panels provide high R-Value thermal resistance, significantly lessening a customer’s energy consumption.

Concerning Grow Greenhouse, Grow Contractors’ Greenhouse Hybrids integrate the efficiency of structurally insulated panels with natural sunlight. It provides flexible multi-tier growing layouts, rollup security/blackout panels, and environmental control.

Furthermore, mCig has partnered with industry leaders and designers to provide a drop and grow solution for the home grower. The Home Grow Rooms are professionally designed, climate controlled rooms. They are suited for beginners and experts.

mCig also offers Consulting Services. This is to help clients navigate state, county, and city regulations for compliancy. Its Consulting Services provide the expertise for this. Additionally, mCig has entered the technology space to satisfy its developing role in technology and in keeping its increasing following informed. mCig also focuses on providing distribution, media and events, and business services within the cannabis industry.

At the beginning of August, mCig announced the extension of its offerings to include merchant processing. The Company has created a new entity, partnering with a merchant provider with more than 10 years of experience, allowing mCig to provide a wide-ranging, seamless, and secure payment solution via a trusted source. After rigorous testing, mCig can provide merchant processing exclusively to cannabis businesses and dispensaries. Its merchant service provides a simple, direct, United States-based solution that can accept credit cards online and at participating dispensaries.

Also, this month, mCig announced a partnership between its Job Search Portal (420JobSearch.com) and ZipRecruiter.com. 420jobsearch.com recently entered into an agreement with ziprecruiter.com to allow both companies to widen the scope of jobs available to job seekers. mCig's 420JobSearch is considered one of the largest job and recruitment sites in the cannabis industry. It has leading job boards for employers, job seekers, as well as recruiters.

Today, mCig announced that it filed with the U.S. Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the year ended April 30, 2017. The Company recorded a record-breaking year. It saw considerable growth in its Revenue, Net Earnings, Cash position, and Balance Sheet. Selected highlights include Revenue from continuing operations for Fiscal Year (FY) 2017 of $4,777,072 versus $1,723,421 from the prior year. This represents an increase of $3,053,651 or roughly 277 percent.

Gross Profit for FY 2017 was $1,896,029 versus $290,773 from the prior year. mCig’s Net Operating Income rose by $2,337,944 to $929,989 for FY 2017 from a Net Loss of ($1,408,955) for the prior year. The Company recorded a $1,527,352 Net Profit, $1,539,233 EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization), and a $32,685 Adjusted Net Income.

mCig, Inc. (MCIG), closed Tuesday's trading session at $0.1899, up 5.56%, on 835,476 volume with 200 trades. The average volume for the last 3 months is 1,454,450 and the stock's 52-week low/high is $0.174/$0.427.

chart

Liberated Syndication, Inc. (LSYN)

The Hot Penny Stocks, Promotion Stock Secrets, Dividend Investor, Wallet Investor, InvestorsHub, Market Exclusive, Stockflare, Penny Stock Hub, Tip Ranks, TradingView, Insider Mole, StockInvest, Investors Hangout, Stockhouse, and Simply Wall St reported previously on Liberated Syndication, Inc. (LSYN), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Liberated Syndication, Inc. engages in the podcast hosting services business in the United States. The Company formerly went by the name Webmayhem, Inc. It changed its name to Liberated Syndication, Inc. in August 2016. OTCQB-listed, Liberated Syndication is based in Pittsburgh, Pennsylvania.

The Company has its OnPublish – Multiple Destination Publishing. Its services provide independent podcasters tools to create a premier podcast and get that podcast into as many platforms as possible. Liberated Syndication is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters’ tools to publish content; and mobile apps for podcasts.

Its publishing platform integrates content delivery to social media and blog platforms via OnPublish, the Company’s Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn). At present, the Libsyn network reaches approximately 90 million monthly unique audience members. The Company hosts more than 4.2 Million media files for over 50,000 podcasts.

In addition, the Company offers advertisement insertion on certain of the producers’ content. Concerning MyLibsyn – Premium Content, it is a total subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One’s subscribers sign up and create one username and password. They can access their subscription across all available apps and one’s branded premium page.

Regarding Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is quick and reliable and unmetered bandwidth and flexible storage space increases over time. Also, The Libsyn custom smartphone app for podcasters involves audiences beyond one’s regular audio or video episodes. Four different types of content are accepted by the app (audio, video, PDF and text). All in one place, a user can offer their audience extras, blog posts, transcripts, and more.

Furthermore, Liberated Syndication has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution. It allows for as many different shows and episodes as needed.

Recently, Liberated Syndication announced that it is proud to be announced as a launch partner supporting the new Podcasts On Pandora. Libsyn worked with Pandora (NYSE:P) to make greater than 400 podcasts available at launch. Pandora brings to podcasting the largest audio listening platform in the United States with more than 70 million active users monthly.

Mr. Rob Walch, VP of Podcaster Relations said, "We are very excited for the incremental growth that Pandora will bring to Podcasting and are thrilled to work directly with Pandora to make so many quality podcasts available at launch, and to bring the rest of our participating shows in 2019."

Liberated Syndication, Inc. (LSYN), closed Tuesday's trading session at $1.30, down 3.70%, on 12,073 volume with 19 trades. The average volume for the last 3 months is 9,490 and the stock's 52-week low/high is $1.05/$1.89.

chart

SolarWindow Technologies, Inc. (WNDW)

Winston Small Cap, Stock Oodles, Stock Gumshoe, AllPennyStocks, TopPennyStockMovers, and SmallCapVoice reported previously on SolarWindow Technologies, Inc. (WNDW), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

SolarWindow Technologies, Inc. is a developer of next generation, transparent, electricity-generating SolarWindow™ coatings. The Company is a developer of electricity-generating windows for tall towers and skyscrapers. The Company previously went by the name New Energy Technologies, Inc. It changed its name to SolarWindow Technologies, Inc. in March of 2015. SolarWindow Technologies has its corporate office in Columbia, Maryland.

The Company’s mission has been to create SolarWindow™ products, which produce substantial amounts of clean electricity, financially reward its customers, and benefit the environment. SolarWindow Technologies creates transparent electricity-generating liquid coatings. Upon application to glass or plastics, the coatings convert passive windows and other materials into electricity generators under natural, artificial, low, shaded, and reflected light conditions.

The Company’s SolarWindow™ technology has been independently validated to generate 50-times the power of a conventional rooftop solar system. In addition, it realizes a one-year payback when modeled on a 50-story building.

SolarWindow™ products are undergoing development to be installed on all four sides of a skyscraper. This turns the whole building into a power generator.

SolarWindow Technologies latest products will be engineered as transparent, tinted, flexible veneers that installers can apply directly over top of existing windows on tall towers and skyscrapers. This expanded product line extends the Company’s market reach beyond new and replacement installations, to include windows now installed on the estimated five million commercial buildings built in the U.S. alone.

SolarWindow™ uses organic materials dissolved into liquid, best for low-cost high-output manufacturing. SolarWindow™ systems can undergo installation on the readily-available sizeable window glass surfaces on tall towers and skyscrapers.

SolarWindow™ can be applied to the sides of tall towers, producing electricity using natural, shaded, and artificial light. SolarWindow™ coatings generate electricity on see-through glass and flexible plastics with colored tints popular to skyscraper glass.

The Company entered Phase III of its Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL).

The primary development goal of the Agreement is the commercialization of SolarWindow™ products. SolarWindow™ is also expanding product development to include applying its electricity-generating coatings onto flexible glass – as thin as a business card (only 0.1-millimeter-thick), which is flexible enough to be bent without breaking or cracking.

SolarWindow Technologies has entered into a Process Integration and Production Agreement with Triview Glass Industries. With the agreement, the Company can now work towards fabricating, at commercial scale and volume, specific transparent SolarWindow™ electricity-generating glass products through integrating its technologies into the Triview manufacturing processes. Via its Agreement with Triview, the Company also plans to develop manufacturing lines for the full-scale fabrication of specific SolarWindow™ electricity-generating products.

Today, SolarWindow Technologies announced that it has advanced collaboration with one of the world’s foremost suppliers of organic photovoltaic materials, used by SolarWindow to coat ordinary glass and turn it into electricity-generating windows. The collaboration with Raynergy Tek supports SolarWindow’s pursuit of high-volume production, increased power output, and enhanced transparency of SolarWindow™ products for tall towers and skyscrapers. Based in Hsinchu, Taiwan, Raynergy Tek is a global leader in organic photovoltaics (OPV) technology.

SolarWindow Technologies, Inc. (WNDW), closed Tuesday's trading session at $3.12, up 2.30%, on 29,773 volume with 73 trades. The average volume for the last 3 months is 57,498 and the stock's 52-week low/high is $1.50/$10.50.

chart

Bright Mountain Media, Inc. (BMTM)

Market Chameleon, Zacks, Street Insider, Dividend Investor, otc.watch, OTC Markets, Digital Journal, Wallet Investor, Stockhouse, MarketWatch, Capital Cube, Morningstar, Simply Wall St, Barchart, Infront Analytics, Glass Door, Insider Tracking, GuruFocus, YCharts, last10k, Marketbeat, InvestorsHub, Market Screener, and 4-Traders reported earlier on Bright Mountain Media, Inc. (BMTM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bright Mountain Media, Inc. is a digital media holding company for online assets primarily targeted to the military and public safety sectors. The Company is an owner, acquirer, and manager of customized websites for military and public safety audiences. A fully integrated media business, Bright Mountain Media has its corporate office in Boca Raton, Florida. The Company lists on the OTC Markets’ OTCQB.

Its businesses include Bright Mountain Publishing, Bright Mountain Ad Network, and Bright Mountain eCommerce. The Company combines content creation, ad delivery, as well as eCommerce into one entity. Bright Mountain Media’s dedication is to providing "those that keep us safe" places to go online. While online, they can do everything from staying up-to-date on news and events affecting them to look for jobs, share information, communicate with the public and more.

Bright Mountain Media announced previously that on December 16, 2016, with an effective date of December 15, 2016, and pursuant to the terms of the Asset Purchase Agreement by and among Bright Mountain Media, Inc., its subsidiary Bright Mountain, LLC, Sostre Enterprises, Inc., Pedro Sostre III and James Love (Asset Purchase Agreement), it completed the acquisition of assets from Sostre Enterprises, Inc. related to the Black Helmet® apparel division. This division includes varied website properties and content, social media content, inventory, and other intellectual property (IP) rights. With the Asset Purchase Agreement, Bright Mountain Media acquired the assets constituting the Black Helmet® brand.

Black Helmet® is a brand that embodies Firefighter culture and principles: Courage, Dedication, Sacrifice, and Tradition. Third-generation firefighter, Mr. James Love, and Internet business and marketing expert, Mr. Pedro Sostre formed Black Helmet®. Black Helmet® clothing and accessories feature designs that are hand drawn, unique, and relay the fearless side of firefighting.

Bright Mountain Media announced in September of 2017 that it acquired 100 percent of the membership interests of Daily Engage. Daily Engage is an advertising network. It connects advertisers with approximately 200 digital publications around the world.

This past October, Bright Mountain Media announced that it entered into a non-binding Letter of Intent (LOI) to acquire Kubient, Inc. in an all-stock transaction. Kubient, headquartered in New York, New York, is a video advertising technology company. It offers a full stack programmatic platform designed to boost publisher revenue and lower advertiser cost across the video advertising ecosystem.

Kip Speyer, Chairman and Chief Executive Officer of Bright Mountain Media, said, "Recognizing the synergies of the companies, we have quickly proceeded to a LOI to acquire Kubient, Inc. If consummated, I believe that this acquisition of Kubient will represent a powerful opportunity for Bright Mountain Media to directly offer our brand advertisers the ability to actually prevent the purchase of fraudulent ad opportunities using machine learning in that critical window of time called the bid-stream.”

Bright Mountain Media, Inc. (BMTM), closed Tuesday's trading session at $2.50, up 5.93%, on 876 volume with 7 trades. The average volume for the last 3 months is 1,038 and the stock's 52-week low/high is $0.40/$3.25.

chart

Nutra Pharma Corp. (NPHC)

Serious Traders, PennyStocks24, StocksToBuyNow, Pumps and Dumps, Winston Small Cap, Streetwise Reports, MyBestStockAlerts, BUYINS.NET, UndiscoveredEquities, Wallstreetlivechat, and Innovative Marketing reported earlier on Nutra Pharma Corp. (NPHC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Nutra Pharma Corp. is a biotechnology company listed on the OTC Markets. The Company specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. These include Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Nutra Pharma is marketing Nyloxin® and Pet Pain-Away™ in the Over-the-Counter (OTC) pain management market. Founded in 2000, Nutra Pharma is based in Coral Springs, Florida.

By way of its subsidiaries, the Company carries out basic drug discovery research and clinical development. The focus of its approach to drug discovery and the development of new therapeutic agents are based on specialized receptor-binding proteins found in nature, particularly those found in snake venom from the cobra.

Nutra Pharma’s leading drug candidates are RPI-78M and RPI-MN. Its MS drug RPI-78M was earlier granted Orphan Status by the Food and Drug Administration (FDA) for the treatment of Pediatric Multiple Sclerosis. Nutra Pharma’s RPI-MN inhibits the entry of many viruses known to cause severe neurological damage in diseases such as encephalitis and AIDS. RPI-MN is undergoing development initially for the treatment of HIV. RPI-78M is undergoing development for the treatment of multiple sclerosis (MS).

Additionally, Nutra Pharma looks for strategic licensing partnerships to reduce the risks associated with the drug development process. The Company’s holding, ReceptoPharm, is developing technologies to produce drugs for HIV and MS.

Nutra Pharma’s Designer Diagnostics subsidiary engages in the research and development (R&D) of diagnostic test kits designed to be used for the quick identification of infectious diseases. These include Tuberculosis (TB) and Mycobacterium avium-intracellulare (MAI).

Nutra Pharma offers several drug products for sale for pain treatment. One is Nyloxin®, the first OTC pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The Company has launched Luxury Feet. This is a new version and packaging of its OTC pain drug Nyloxin. Another product is Nyloxin Extra Strength. This is the only non-narcotic and non-addictive treatment for severe (Stage 3) pain. Moreover, the Company has its Pet Pain-Away. This is the first OTC product to treat pain in companion animals without side effects. Pet Pain-Away is a homeopathic, non-narcotic, non-addictive, OTC pain reliever.

In September 2018, Nutra Pharma announced that its work with EuroAmerican IP, LLC resulted in a listing of its Nyloxin® product line on the website, www.GoVets.com. GoVets is the online marketplace under the National Veteran Small Business Coalition (NVSBC) to buy from VA-verified Service-Disabled Veteran-Owned Small Businesses (SDVOSBs).

With growing concern regarding consumers using opioid and acetaminophen-based pain relievers, Nyloxin® offers an alternative, which does not rely on opiates or non-steroidal anti-inflammatory drugs, known as NSAIDs, for their pain relieving effects. Nyloxin® has a well-defined safety profile.   

          

Nutra Pharma Corp. (NPHC), closed Tuesday's trading session at $0.0004, even for the day, on 1,651,521 volume with 4 trades. The average volume for the last 3 months is 13,821,862 and the stock's 52-week low/high is $0.00009/$0.0069.

chart

Purebase Corp. (PUBC)

InvestorsHub, MarketWatch, 4-Traders, OTC Markets, and Stockhouse reported previously on Purebase Corp. (PUBC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Purebase Corp. centers on delivering high quality organic mineral products for the agricultural sector. A diversified, natural, and industrial mineral resource enterprise, the Company concentrates on the acquisition, development, mining, and marketing of industrial and natural mineral properties in California, Nevada, and the rest of the U.S. as its chief priority. Purebase has its headquarters in Ione, California and the Company’s shares trade on the OTC Markets’ OTCQB.

Purebase has created Purebase Networks. This is an AgTech startup. Purebase Networks concentrates on combining Internet of Things (IoT) agricultural sensors, wireless networking, and also cloud technologies to deliver the industry's first vertically integrated agricultural supply chain.

Purebase Networks will partner with Purebase Corp. to deliver proprietary, organic soil amendments for farmers. Purebase Networks will also provide farmers with access to Purebase Networks' proprietary "Big Data" analytics. This is to provide more visibility into crop and soil performance.

Pertaining to the agriculture industry, Purebase provides soil amendment and fertilizer solutions, which are of major benefit to large commercial farming operations and retail consumer markets. Purebase Grow is a total family of soil amendment products.

Grow products include Purebase Humate Advantage; Purebase Potassium & Sulfate Advantage; Purebase Soil Advantage; Purebase Shade Advantage; and Purebase Fulvic Advantage. The focus of these products is to provide a better, more natural way to grow, manage, and increase yield on the farm and deliver higher quality products to consumers’ tables.

Concerning the construction industry, Purebase provides a Supplementary Cementitious Material (SCM). This is an additive that may be used in cement for large infrastructure construction projects for government, commercial, and residential buildings. Purebase Build SCM appreciably lessens greenhouse gas emissions and harmful particulate matter. Moreover, it reduces the overall cost of concrete. This is while increasing its strength.

Regarding its facilities and properties, the Company’s focus is on the commercialization of its three green mining properties. It owns two pozzolan projects, one in Northern California, and the other in Southern California. These serve the regions’ primary markets for the agricultural and construction sectors. Purebase’s potassium-sulfur project is in south-central Nevada near the Company’s central valley agricultural market.

Purebase Corp. (PUBC), closed Tuesday's trading session at $0.15, up 11.11%, on 100 volume with 1 trade. The average volume for the last 3 months is 3,737 and the stock's 52-week low/high is $0.039/$0.20.

chart

RavenQuest BioMed, Inc. (RVVQF)

Stockwolf, OTC Markets, EconoTimes.com, TradingView, Dividend Investor, New Cannabis Ventures, Morningstar, Stockhouse, GlobeNewswire.com, Marketwatch, InvestorsHub, Marketfy, Barchart, Investopedia, Ceo.ca, Investing News Alerts, and Investors Hangout reported on RavenQuest BioMed, Inc. (RVVQF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A diversified publicly traded cannabis company, RavenQuest BioMed, Inc. is headquartered in Vancouver, British Columbia. It has divisions centered upon cannabis production, management services and consulting, and specialized research and development (R&D). Incorporated in 1987, the Company previously went by the name Ravencrest Resources, Inc. It changed its name to RavenQuest BioMed, Inc. in September of last year.

Today, RavenQuest BioMed announced that the OTC Markets Group advised the Company of its qualification and confirmed start of trading on the OTCQB market in the U.S, with immediate effect.  RavenQuest’s common shares began trading under the symbol “RVVQF”.

The Company has a research partnership with McGill University (Montreal, Quebec). The work will be conducted via collaboration between two McGill laboratories. One is through Dr. Donald Smith – patented technologies for improvement of crop yields. The other is through Dr. Mark Ware – medical cannabis researcher; Director of clinical research at the Allen Edwards Pain Management Unit at the McGill University Health Center (MUHC).

RavenQuest BioMed’s Services Division delivers wide-ranging, integrated solutions to companies in the cannabis industry. The Company’s turnkey, end-to-end offering provides growing and drying technologies, patient and genetic management systems, as well as security management solutions.

Last week, RavenQuest BioMed announced it appointed Dr. Simerjeet Kaur, PhD, to lead Scientific Research & Development. She will lead RavenQuest’s R&D and scientific training efforts, specifically relating to the development of new high yielding, stress resistant Cannabis varieties for medicinal and recreational purposes. Dr. Kaur is an expert in plant breeding, genetics, plant physiology, as well as biochemistry.

RavenQuest BioMed has completed its Bloomera acquisition. It completed the acquisition of 8649081 Canada, Inc. (Bloomera), which is a Markham, Ontario headquartered licensed producer of cannabis under the Access to Cannabis for Medical Purposes Regulations.

With this transaction, RavenQuest BioMed acquired all of the outstanding share capital of Bloomera in consideration for a cash payment of $15,000,000, and the issuance of 10,400,000 common shares to the existing shareholders of Bloomera.

At present, Bloomera holds a Health Canada License to Cultivate and will initially add roughly 2,000 kilograms of annual production of cannabis to RavenQuest’s investment division. In addition, RavenQuest owns Alberta Green Biotech. This is an Edmonton, Alberta facility with expected annual production of roughly 7,000 kilograms that will be ready for cultivation in mid-summer 2018.

This week, RavenQuest BioMed announced that it signed a Memorandum of Understanding (MOU) with Fort McMurray #468 First Nation (FM 468) to collaborate in the development, operation, and also financing of a purpose-built facility for the production of cannabis on lands controlled by FM 468.

RavenQuest has developed an indigenous-focused, end-to-end solution for cannabis production and sale on sovereign land.  It will provide its expertise to deliver the technical knowledge, staff resources, and financing opportunities as they relate to the development of the Production Facility, initially sized at 24,000 square feet.  In consideration, RavenQuest will receive a 30 percent ownership interest in such a facility.

RavenQuest BioMed, Inc. (RVVQF), closed Tuesday's trading session at $0.361, up 1.40%, on 27,896 volume with 38 trades. The average volume for the last 3 months is 102,477 and the stock's 52-week low/high is $0.289/$2.50.

chart

Black Cactus Global, Inc. (BLGI)

StreetInsider, Insider Financial, The Street, 4-Traders, Morningstar, Stockopedia, Dividend Investor, PennyStockHub, Stockhouse, Simply Wall St, MarketNewsUpdates, Tip Ranks, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, and InvestorsHangout reported previously on Black Cactus Global, Inc. (BLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development business focusing on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. The Company is developing Blockchain applications for FinTech, Healthcare, Media and Supply Chain employing smart contracts and machine learning. Black Cactus Global is based in Las Vegas, Nevada.

The Company’s strategic plan is to become the first totally integrated digital financial institution with Blockchain technology as its operating foundation. Black Cactus Global’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems.

In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, as well as FinTech & MedTech. Black Cactus Global specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.

Black Cactus Global announced in January of this year that it entered into an MOU (Memorandum of Understanding) with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With the MOU, Black Cactus Global will become the largest stakeholder of a global Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its innovative Blockchain based IP.

In May 2018, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). The agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable Black Cactus to scale-up development activities.

Regarding Healthcare, Black Cactus Global concentrates on creating opportunities for digital health economies via Blockchain with AI, IoT, and Machine Learning. Pertaining to Energy, the Company offers privatized network grid provision to isolate green energy from traditional energy sources and a chain code logic to manage energy distribution and estimation.

Black Cactus Global, Inc. (BLGI), closed Tuesday's trading session at $0.0115, up 15.00%, on 525,955 volume with 62 trades. The average volume for the last 3 months is 175,022 and the stock's 52-week low/high is $0.0089/$0.699.

chart

Sport Endurance, Inc. (SENZ)

Penny Stock Explosion, BullRally, Global Equity Report, CoolPennyStocks, Promotion Stock Secrets, Stock Beast, StockRockandRoll, Stock Traders Chat, StockMister, 24-7 Stock Alert, HotOTC, Simply Best Penny Stocks, Top Best Pennystocks, Open Water Investments, OTC Picks, Penny Invest, Stock Rich, and StockEgg reported earlier on Sport Endurance, Inc. (SENZ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Sport Endurance, Inc. develops, markets, and distributes nutritional supplement products throughout the United States. The Company’s aim is to improve health through providing quality and effective nutritional supplements. All Sport Endurance brand products are manufactured in America in Food and Drug Administration (FDA)-inspected facilities with strict quality control that follows Good Manufacturing Practices (GMP). Sport Endurance is based in Jersey City, New Jersey.

Sport Endurance’s supplements are natural supplements. They contain no ingredients that would require a prescription. The all-natural dietary supplements meet wellness needs without using harsh synthetic chemicals.

Concerning nutritional supplement products, the Company’s chief focus is on three areas of health that most directly affect the lives of many active adults. These are Total Wellness, Performance, and Recovery. Sport Endurance has launched its website to market men’s health products direct to consumers.

Sport Endurance has also created a cryptocurrency lending subsidiary. Yield Endurance (a wholly-owned subsidiary) is its newly created cryptocurrency lending subsidiary. Yield Endurance provides institutional investors a lending program for their cryptocurrency assets.

Through Yield Endurance, and its strategic agreement with Madison Partners, Sport Endurance concentrates on increasing liquidity and institutional participation in the cryptocurrency markets through providing institutional investors, through Madison Partners, the ability to borrow, hedge, and arbitrage cryptocurrencies that trade on the different cryptocurrency exchanges. This includes Bitcoin, Bitcoin Cash, Ethereum and Litecoin.

Last week, Sport Endurance announced the closing of roughly $2.8 million in a private placement of its units, the proceeds of which the Company plans to use to explore strategic alternatives in the cannabidiol (CBD), hemp, as well as legal cannabis industries.

Mr. David Lelong, Sport Endurance’s Chief Executive Officer, stated, “The regulatory landscape continues to evolve for CBD products, allowing us to leverage our core competency as an online marketer to potentially offer these products through e-commerce.”

Today, Sport Endurance announced that it made a $2.2 million investment in TruPet LLC, the parent company of TruDog, a family-owned pet food company committed to supplying the TruDog line of nutritional food, supplements, and pet care products for dogs, cats, and horses. The $2.2 million investment by Sport Endurance is made in combination with a large investment from Cambridge Companies SPG, a highly respected strategic opportunity investment firm as part of TruPet’s $5.2 million oversubscribed Series A round.

Sport Endurance, Inc. (SENZ), closed Tuesday's trading session at $0.37, down 5.13%, on 17,498 volume with 7 trades. The average volume for the last 3 months is 1,647 and the stock's 52-week low/high is $0.10/$1.20.

chart

Maricann Group, Inc. (MRRCF)

OTC Markets, Barchart, Weed Newswire, Stockhouse, Investopedia, Insider Financial, YCharts, The Street, MarketWatch, 4-Traders, NewCannabisVentures.com, Marketwired, Investors Hub, and TradingView reported on Maricann Group, Inc. (MRRCF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Established in 2013, Maricann Group, Inc. produces and distributes marijuana for medical purposes. It offers dried marijuana, cannabis oil, and gums. Additionally, the Company provides accessories. This includes vaporizers, grinders, and other paraphernalia. Maricann Group has its headquarters in Burlington, Ontario, and Munich, Germany. The Company has production facilities in Langton, Ontario. Maricann Group lists on the OTC Markets’ OTCQB.

Maricann Group is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Maricann Group has federal licenses in Canada to cultivate, extract, formulate, as well as distribute cannabis.

In Langton, Ontario, Maricann operates a medicinal cannabis cultivation, extraction, and formulation and distribution business under federal license from the Government of Canada, and Dresden, Saxony, Germany.

The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. At present, Maricann is undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, to support existing and future patient growth.

Maricann Group’s Germany-based Ebersbach facility targets the substantial European market with 820,000 sq. ft. of cultivation space and greater than 12,000 patients. Maricann has developed educational programming for patients and healthcare professionals. Through exclusive pharmacy agreements with roughly20 percent of the nation’s pharmacies, Maricann is working to become a leading provider of cannabis at physical point-of-sale locations that patients trust.

In August of 2017, Maricann Group acquired NanoLeaf Technologies. NanoLeaf is a biotechnology company. It has licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.

Recently, Maricann Group announced that it received all of the required approvals from Health Canada to begin cultivation in Phase One of the Company’s new, state-of-the-art grow facility in Langton, Ontario. This is Maricann Group’s third license issued by Health Canada.

Furthermore, in April, Maricann Group announced that it is now part of an exclusive group of Canadian Licensed Producers to be Good Manufacturing Practice (GMP) certified in accordance with the European Medicines Agency’s GMP standards.

Last week, Maricann Group announced that it completed the acquisition of all outstanding shares of Haxxon AG. This acquisition of Haxxon forms an essential aspect of Maricann’s European expansion strategy.

Maricann is now positioned to enter the Swiss market via Haxxon’s production of feminized high CBD cannabis plants.  Haxxon operates within a 6,000 sq. m. (approximately 64,500 sq. ft.) indoor facility in Regensdorf, Switzerland.

Maricann Group, Inc. (MRRCF), closed Tuesday's trading session at $0.775, up 10.89%, on 373,152 volume with 266 trades. The average volume for the last 3 months is 236,811 and the stock's 52-week low/high is $0.65/$3.59.

chart

NightFood Holdings, Inc. (NGTF)

Equities.com, Barchart, MarketWatch, and Innovative Marketing reported on NightFood Holdings, Inc. (NGTF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

NightFood Holdings, Inc. is a snack company headquartered in Tarrytown, New York. The Company’s devotion is to provide consumers delicious, “better-for-you” choices for evening snacking. NightFood creates, manufactures, and distributes products to help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly manner. Incorporated on October 16, 2013, NightFood Holdings lists on the OTC Markets Group’s OTCQB.

NightFood has its Midnight Chocolate Crunch Bar and its NightFood-Cookies n’ Dreams Bar in its present product lineup. NightFood is working to add more offerings to its line of “better-for-you” nighttime snacks.

The Company is exploring product development and major distribution opportunities in other popular snack formats such as ice cream and "bites." Furthermore, gluten-free versions of NightFood products are currently undergoing development.

NightFood Holdings is building a Scientific Advisory Panel to provide continuing expertise and guidance regarding new product development and formulations. This announcement came in response to research presented in June at SLEEP 2017, the 31st Annual Meeting of the Associated Professional Sleep Societies LLC, and published in major media outlets around the world.

The study was funded by the National Institutes of Health. It was conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania. The study explored the influence of eating at night on sleep quality and overall health.

Last week, NightFood Holdings announced that venture capitalist and bio-technology consultant, Mr. Jeffrey Robinson, has been engaged by the Company to evaluate applications of CBD within the nighttime snack space and other related areas of opportunity. Mr. Robinson is Managing Director of MJ Accelerator, which is a wholly-owned division of Player's Network, a diversified holding company. He is also Chief Executive Officer at Internet Bull Report.

NightFood is now evaluating opportunities to introduce snacks with cannabidiol (CBD), strains of which are broadly accepted to promote better sleep. The Company is exploring the CBD space with guidance from Company Advisory Board member Dr. Michael Grandner, Director of the Sleep and Health Research Program at the University of Arizona.

In addition, last week, Player’s Network, Inc. (PNTV), a diversified holding company operating in media and marijuana, announced a strategic partnership and Development Agreement with NightFood Holding to develop a CBD infused line of nighttime snacks.

Green Leaf Farms Holdings is a subsidiary of PNTV. Green Leaf is working with Mr. Robinson and NightFood to commence developing a line of CBD-infused nighttime edibles. Green Leaf will be responsible for the cultivation and extraction of the CBD oils to infuse into the new line of products. These products would be formulated to support and promote better sleep.

NightFood Holdings, Inc. (NGTF), closed Tuesday's trading session at $0.1949, up 2.69%, on 141,063 volume with 43 trades. The average volume for the last 3 months is 166,245 and the stock's 52-week low/high is $0.09/$0.695.

chart

RepliCel Life Sciences, Inc. (REPCF)

OTCPicks, Greenbackers, Investor Spec Sheet, StockGuru, TheStockAdvisor, 24-7 Stock Alert, Beacon Equity Research, Crazy Carl, Global Equity Report, The Green Baron, Club Penny Stocks Network, Streetwise Reports, InvestorSoup, Penny Stock Explosion, SmallCapReview, Stock Preacher, Penny Stocks Finder, ShazamStocks, and StockHideout reported earlier on RepliCel Life Sciences, Inc. (REPCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

RepliCel Life Sciences, Inc. is a regenerative medicine company listed on the OTC Markets’ OTCQB. The Company concentrates on the development of cell therapies for aesthetic and orthopedic conditions. These include aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. All of its product candidates are based upon RepliCel’s unique technology using cell populations isolated from a patient's healthy hair follicles. RepliCel Life Sciences has its headquarters in Vancouver, British Columbia.

The Company’s product pipeline consists of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, as well as RCH-01 for hair restoration. Currently, RCH-01 is being co-developed with, and under exclusive license by, Shiseido for certain Asian countries. In addition, RepliCel has developed a proprietary injection device RCI-02, optimized for the administration of its products and licensable for use with other dermatology applications.

RepliCel Life Sciences is investing in research that the Company states has the potential to lead to a number of future products. These include other chronic tendinopathies (patellar tendinosis, tennis elbow, golfer’s elbow, rotator cuff); other dermatologic indications (acne scaring, etc.); gingivitis, and allogeneic versions of the Company’s proven autologous cell therapies.

In September 2017, RepliCel Life Sciences announced the timely arrival of its functioning RCI-02 prototypes. These became ready to be showcased to potential end users and licensing partners.

With these prototypes in-hand, the Company is engaging with important opinion leaders and clinical dermatologists to ask for feedback vitally important to aligning successful early adoption of the device, design clinical studies demonstrating its advantages in select applications, and position RepliCel for an anticipated successful launch of an approved next-generation dermal injector in the European market this year.

Last month, RepliCel Life Sciences announced that it signed a Binding Term Sheet with YOFOTO (China) Health Industry Co. Ltd. (YOFOTO) to establish a strategic partnership in Greater China (Mainland China, Hong Kong, Macau, and Taiwan). The deal involves an up-front investment of USD $6,500,000 and potential pre-commercial, non-dilutive milestones payments of another USD $2,800,000.

Moreover, the Term Sheet commits YOFOTO to another USD $1,000,000 in potential post-commercial non-dilutive milestone payments, several million in dedicated program funding in Greater China over the next five years, and future royalty payments calculated on gross product sales in the Territory.

RepliCel Life Sciences, Inc. (REPCF), closed Tuesday's trading session at $0.25, up 0.77%, on 12,073 volume with 3 trades. The average volume for the last 3 months is 10,396 and the stock's 52-week low/high is $0.2458/$0.5185.

chart

Processa Pharmaceuticals, Inc. (PCSA)

NetworkNewsWire, Stockflare, MarketWatch, Biz Journals, Marketbeat, TradingView, PR Newswire, Stockopedia, Infront Analytics, Stockhouse, Barchart, Dividend Investor, Morningstar, YCharts, InvestorsHub, Simply Wall St, last10k, Biospace, 4-Traders, and Financial Content reported on Processa Pharmaceuticals, Inc. (PCSA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Processa Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company listed on the OTC Markets’ OTCQB. It is developing products to improve the survival and/or quality of life for patients who have high unmet medical need conditions. In October 2017, the Company acquired the assets of Promet Therapeutics, LLC. It assembled a proven regulatory science development team, management team, and Board of Directors. Processa Pharmaceuticals has its corporate headquarters in Hanover, Maryland.

On December 6, 2018, Processa Pharmaceuticals announced that its stock began trading on the OTCQB Market (OTCQB) after successfully up-listing from the OTC Pink Market. Processa’s belief is that its listing on the OTCQB will provide enhanced investor benefits. This includes higher reporting standards, greater access to analyst coverage and news services, and more comprehensive compliance requirements.

The Processa Team are experts in developing drug products from IND enabling studies to NDA submission. The Company’s plan is to have a pipeline of drugs that already have some proof-of-concept clinical data supporting its clinical use in the indication selected and in 2-4 years subsequent to acquisition will either have completed the pivotal study or be ready for a pivotal study and out-licensing.

Processa Pharmaceuticals’ lead product is PCS-499. It will be investigated for the treatment of Necrobiosis Lipoidica, a necrotizing skin condition, caused by a number of pathophysiological changes. PCS-499 represents the first Processa Pharmaceuticals drug that can potentially be used in several unmet medical need conditions.

A second unmet medical need under investigation is the use of PCS-499 to treat radiation-related adverse effects in head & neck cancer. For both indications there is no Food and Drug Administration (FDA) approved treatments. Moreover, the current standard of care is not adequate for patients.

Recently, Processa Pharmaceuticals announced that the FDA granted the Company clearance to proceed with a Phase 2 clinical trial of PCS-499 in patients with Necrobiosis Lipoidica (NL) under a recently submitted Investigational New Drug (IND) application. NL is a chronic, disfiguring condition affecting the skin and the tissue under the skin usually on the lower extremities with no presently approved FDA treatments. PCS-499 may provide a solution since PCS-499 and its metabolites affect several biological pathways, a number of which contribute to the pathophysiology associated with NL.

Processa Pharmaceuticals, Inc. (PCSA), closed Tuesday's trading session at $3.60, up 75.61%, on 100 volume with 1 trade. The average volume for the last 3 months is 765 and the stock's 52-week low/high is $1.50/$5.125.

chart

InPlay Oil Corp. (IPOOF)

Zacks, OTC Markets, Dividend Investor, GuruFocus, Market Screener, Stockwatch, MarketWatch, Private Capital News Wire, Stockhouse, Uptick Newswire, Penny Stock Hub, Energy Now, Barchart, Wallmine, InvestorX, TradingView, The Street, Wallet Investor, 4-Traders, and InvestorsHub reported earlier on InPlay Oil Corp. (IPOOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

InPlay Oil Corp. is a growth-oriented light oil development and production enterprise. The Company focuses on large oil in place pools with low recovery factors, low declines, and long life reserves primarily targeting the Cardium Formation in the Province of Alberta. Its light oil focus properties provide high netbacks with quick payout on new drills. InPlay Oil is headquartered in Calgary, Alberta and the Company lists on the OTC Markets’ OTCQX.

InPlay Oil’s Cardium assets are located in West Central Alberta centered in the Pembina and Willesden Green pools. These pools have large oil in place reserves. Moreover, there are still large reserves of unrecovered oil.

The Company’s Belly River light oil property is on the east side of the Pembina Cardium Pool. Belly River growth opportunities are concentrated around targeting oil in tight sands with low recovery factors by drilling horizontal multi-frac wells.

InPlay Oil also holds rights on a developing Duvernay light oil play. Depths are only a bit more than that of the Cardium sand in Willesden Green. This results in well costs that are manageable for the Company.

In November, InPlay Oil announced its financial and operating results for the three and nine months ended September 30, 2018. The Company realized record quarterly production of 4,773 boe/d. This represents a 17 percent increase versus Q3 2017, resulting in average production of 4,529 boe/d for the first nine months of 2018, a 16 percent increase versus the first nine months of 2017. In addition, total oil and liquids weighting increased to 70 percent completely attributable to light oil growth over the same respective periods.

InPlay Oil generated Revenues of $22.8 million. This represents an increase of 57 percent from Q3 2017 (96 percent derived from light oil and liquids). Light oil Revenues in Q3 increased 64 percent over Q3 2017 to $19.7 million. Operating Income was $13.0 million. This represents a 110 percent increase over Q3 2017 with a corresponding 80 percent increase in operating netback to $29.51 per boe over the same particular period.

InPlay Oil Corp. (IPOOF), closed Tuesday's trading session at $0.626, down 4.99%, on 28,500 volume with 12 trades. The average volume for the last 3 months is 7,096 and the stock's 52-week low/high is $0.651/$1.551.

chart

The QualityStocks Company Corner

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR), a Canadian Licensed Producer of premium cannabis products, was highlighted in a recent article published by The Motley Fool, titled ‘This Tiny Marijuana Stock Could Be Better Prepared for the Coming Supply Glut Than Canopy Growth and Tilray’ authored by Keith Speights. To view the full article, visit: http://nnw.fm/VLf0c.

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.70, up 6.94%, on 176,416 volume with 268 trades. The average volume for the last 3 months is 106,596 and the stock's 52-week low/high is $2.74/$8.00.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN) (“GRYN" or the “Company"), an innovative full-scope, science driven, premium cannabis cultivation enterprise, has been approved by the OTC Markets Group Inc. to up-list to the OTCQB exchange.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.4098, up 6.46%, on 1,345 volume with 2 trades. The average volume for the last 3 months is 14,177 and the stock's 52-week low/high is $0.0175/$0.508.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions (OTC: SGSI), a single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and solutions to the service provider (carrier) and corporate enterprise markets, will host an investor webinar and live Q&A session on Wednesday, December 19, at 11:00 a.m. EST. To view and participate in the webinar, please visit: https://www.redchip.com/events/36/spectrum-global-webinar.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed the day's trading session at $0.241, up 4.78%, on 10,400 volume with 7 trades. The average volume for the last 3 months is 19,964 and the stock's 52-week low/high is $0.15/$2.59.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions (OTC: DVLP), an emerging leader in the cannabidiol (“CBD”) products marketplace, supports the cannabis industry by offering trustworthy software and technology. To view the full article, visit: http://nnw.fm/DwD2g.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0135, off by 18.67%, on 76,150 volume with 17 trades. The average volume for the last 3 months is 636,064 and the stock's 52-week low/high is $0.0125/$0.14.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright Inc. (TSXV: THRM), ("Therma Bright" or the "Company"), a progressive medical device technology company, today announces that it has received the prototype of its pain relief device and provides an update on its TherOZap™ technology.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.0099, even for the day. The average volume for the last 3 months is 558 and the stock's 52-week low/high is $0.0098/$0.0289.

Recent News

chart

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announced today that its wholly owned subsidiary,  Natural Health Services Ltd. ("NHS"), will partner with HelloMD, a leading online cannabis telehealth company, to offer telemedicine services to its patients to provide more Canadian communities with convenient access to medical cannabis advice.

Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $2.36, off by 1.43%, on 50,233 volume with 116 trades. The average volume for the last 3 months is 100,725 and the stock's 52-week low/high is $2.25/$16.00.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

A foremost omni-direct lifestyle company, Youngevity International, Inc. (NASDAQ: YGYI) offers products from the top eight selling retail categories. In addition, it offers a fusion of the direct selling business model. The company has a growing line of products coupled with its innovative business opportunity. Youngevity International is based in Chula Vista, California. The company was added to the Russell Microcap Index in June 2018.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $6.54, off by 3.40%, on 68,799 volume with 402 trades. The average volume for the last 3 months is 570,357 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing The Supreme Cannabis Company Inc. (TSX-V: FIRE) (OTCQX: SPRWF) (FRA: 53S1). Also today, NetworkNewsWire released a report on the company detailing how SPRWF is building on the successes of an expansion and marketing effort that brought in a 229 percent year-over-year sales growth during the past year, thanks largely to its high-quality 7ACRES brand.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.00, off by 2.68%, on 229,371 volume with 190 trades. The average volume for the last 3 months is 691,998 and the stock's 52-week low/high is $0.939/$2.789.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSXV: RIV) today provided an update that an entity controlled by its portfolio company TerrAscend Corp. (“TerrAscend”) (CSE: TER; OTCQX: TRSSF), NETA NJ LLC (“NETA”), has been selected by the State of New Jersey Department of Health to apply for final approval to operate a vertically integrated Alternative Treatment Center (ATC), which would permit it to cultivate, process and sell medical cannabis in the state.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $3.11, off by 4.89%, on 232,201 volume with 397 trades. The average volume for the last 3 months is 414,892 and the stock's 52-week low/high is $2.94/$11.82.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) ("CIIX" or the "Company"), the premier financial information website for Chinese-speaking investors, today announced the appointment of Alex Hamilton, as Chief Financial Officer of its wholly-owned subsidiary, CBD Biotechnology, LTD. Mr. Hamilton's focus will be on the execution of the previously announced spin-off of CBD Biotech, as well as overseeing a variety of corporate functions, including accounting, business operations and pricing, financial planning and analysis, financial reporting, investor relations, internal Audit, SEC reporting, tax and treasury functions.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.5152, off by 6.33%, on 127,988 volume with 70 trades. The average volume for the last 3 months is 528,736 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces the production of the first commercial production run of Hygee™, its new, original medical device to fight sexually transmitted infections (STIs). The official launch is scheduled for early 2019. Also today, the company was highlighted in a report by Financialnewsmedia.com, looking at how the global medical device market is expected to reach an estimated $409.5 Billion by 2023, and it is forecast to grow at a CAGR of 4.5% from 2018 to 2023.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7977, off by 5.70%, on 16,737 volume with 28 trades. The average volume for the last 3 months is 121,738 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX-V: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce the appointment of Andreas Sander as President, European Operations, and Managing Director of ABcann Germany GmbH, VIVO’s German subsidiary. Mr. Sander will assume the position effective January 1, 2019.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.542, off by 5.13%, on 549,676 volume with 235 trades. The average volume for the last 3 months is 397,771 and the stock's 52-week low/high is $0.5198/$3.293.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $2.20, off by 12.00%, on 19,497 volume with 35 trades. The average volume for the last 3 months is 4,226 and the stock's 52-week low/high is $1.52/$5.00.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (“DPW” or the “Company”), announced today that its Board of Directors has authorized the officers of DPW to pursue a separate listing and initial public offering of its DPW Technology Group, which will include the Company’s Defense and Aerospace businesses as well as the Electronics and Power Solutions businesses. The Company anticipates completing the initial public offering in the first half of 2019 and expects that DPW will remain a majority shareholder of the new entity after the offering has been completed.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.1023, off by 24.39%, on 5,367,546 volume with 6,464 trades. The average volume for the last 3 months is 1,275,232 and the stock's 52-week low/high is $0.135/$5.77.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.